Koyfin Home > Directory > Health Care > Kura Oncology > Long-Term Debt / Capital

Kura Oncology Long-Term Debt / Capital Chart (KURA)

Kura Oncology annual/quarterly Long-Term Debt / Capital from 2016 to 2020.
  • Kura Oncology Long-Term Debt / Capital for the quarter ending June 06, 2020 was $3m a 10.89% increase of 0m year over year
  • Kura Oncology Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $3m a 10.89% increase of 0m year over year
  • Kura Oncology Annual Long-Term Debt / Capital for 2019 was $3m a -39.09% decrease of -1m from 2018
  • Kura Oncology Annual Long-Term Debt / Capital for 2018 was $4m a -43.81% decrease of -2m from 2017
  • Kura Oncology Annual Long-Term Debt / Capital for 2017 was $6m a -78.21% decrease of -5m from 2016
Other Ratios Metrics:
  • Kura Oncology Total Debt / Capital for the quarter ending September 09, 2018 was $3m a -135.60% decrease of -5m year over year
  • Kura Oncology Other Liabilities for the quarter ending December 12, 2018 was $0m a -59.86% decrease of 0m year over year
  • Kura Oncology Total Debt / Equity for the quarter ending September 09, 2018 was $4m a -147.66% decrease of -5m year over year
View Chart On Koyfin

Quarterly KURA Long-Term Debt / Capital Data

06/2020$3m
03/2020$4m
12/2019$3m
09/2019$3m
06/2019$3m
03/2019$5m
12/2018$4m
09/2018$2m
06/2018$3m
03/2018$4m

Annual KURA Long-Term Debt / Capital Data

2019$3m
2018$4m
2017$6m
2016$11m
2014$-55m